Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04447157
Other study ID # xuwen2020-465
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 1, 2016
Est. completion date June 20, 2020

Study information

Verified date June 2020
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

By comparing the preoperative data and postoperative data of 9 patients of microspherophakia, we concluded that the 6-point transscleral suture fixation of a 3-looped haptics posterior chamber intraocular lens (PC-IOL) through scleral pockets was a feasible method of PC-IOL implantation in the surgical treatment of microspherophakia.


Recruitment information / eligibility

Status Completed
Enrollment 9
Est. completion date June 20, 2020
Est. primary completion date June 10, 2020
Accepts healthy volunteers No
Gender All
Age group 10 Years to 80 Years
Eligibility Inclusion Criteria:

- Microspherophakia was diagnosed and lens diameter<9mm;

- The lens subluxation was beyond the range of one quadrant and glasses cannot correct the vision;

- Lens dislocated into the anterior chamber;

- Lens dislocation caused elevated intraocular pressure (IOP);

- The lens contacted the corneal endothelium;

- Cataract;

- Corneal endothelial cell density>1000/mm2;

- The fundus was normal without retinal detachment, severe macular disease and optic nerve atrophy;

- There was possible improvement in postoperative visual acuity measured by retinometer.

Exclusion Criteria:

- The lens is centered and the position of the lens is stable;

- Glasses can correct the vision obviously;

- The reason for the elevated IOP was independent with the lens;

- A high possibility of corneal decompensation after surgery;

- Fundus function was poor and it is not expected to improve the vision after surgery;

- Combined with other ocular diseases which were not suitable for IOL implantation;

- Combined with a systemic disease that the patient cannot tolerate the surgery.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Second Affiliated Hospital, School of Medicine, Zhejiang University

Outcome

Type Measure Description Time frame Safety issue
Primary Visual function Best corrected visual acuity (BCVA) measured using a decimal chart 6 month postoperation
Primary Visual function uncorrected distance visual acuity (UDVA) measured using a decimal chart 6 month postoperation
Primary Intraocular pressure intraocular pressure measured using non-contact tonometer 6 month postoperation
Primary PCIOL tilt degree PCIOL tilt degree measured using Ultrasound biomicroscope 6 month postoperation
Primary PCIOL decentration distance PCIOL decentration distance measured using Ultrasound biomicroscope 6 month postoperation
Primary Endothelial cell density Endothelial cell density was measured by specular microscopy 6 month postoperation
Primary Anterior chamber depth Anterior chamber depth measured using Ultrasound biomicroscope 6 month postoperation